These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 23576896)

  • 21. A systematic literature review of health state utility values in head and neck cancer.
    Meregaglia M; Cairns J
    Health Qual Life Outcomes; 2017 Sep; 15(1):174. PubMed ID: 28865475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Examination of assumptions in using time tradeoff and standard gamble utilities in individuals with spinal cord injury.
    Lin MR; Yu WY; Wang SC
    Arch Phys Med Rehabil; 2012 Feb; 93(2):245-52. PubMed ID: 22289233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The utility score of epilepsy with partial seizure measured by TTO, VAS, and EQ-5D in the general Korean population.
    Kang HJ; Kang E; Jo MW; Park EJ; Yoon S; Lee EK
    Epilepsy Res; 2014 Jul; 108(5):963-71. PubMed ID: 24679945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Feasibility, comparability, and reliability of the standard gamble compared with the rating scale and time trade-off techniques in Korean population.
    Kim SH; Lee SI; Jo MW
    Qual Life Res; 2017 Dec; 26(12):3387-3397. PubMed ID: 28801862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disutility of Cognitive Processing Speed (CPS) Impairment in the Context of Multiple Sclerosis: A Time Trade-Off (TTO) Elicitation Study.
    Benedict RHB; Vo P; Adlard N; Grennan O; Enstone A; Bridge D; Wyn R; Cohan SL
    Clinicoecon Outcomes Res; 2024; 16():55-67. PubMed ID: 38348373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The utility assessment method order influences measurement of parents' risk attitude.
    Finnell SM; Carroll AE; Downs SM
    Value Health; 2012; 15(6):926-32. PubMed ID: 22999143
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Utility assessment in patients with mental disorders: validity and discriminative ability of the time trade-off method.
    König HH; Günther OH; Angermeyer MC; Roick C
    Pharmacoeconomics; 2009; 27(5):405-19. PubMed ID: 19586078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Utilities for advanced basal cell carcinoma.
    Shingler SL; Garside J; Samanta K; Lear JT; Keohane S; Lloyd AJ
    J Med Econ; 2013; 16(6):777-83. PubMed ID: 23621505
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Social preferences for health states associated with acute myeloid leukemia for patients undergoing treatment in the United Kingdom.
    Castejón N; Cappelleri JC; Cuervo J; Lang K; Mehta P; Mokgokong R; Mamolo C
    Health Qual Life Outcomes; 2018 Apr; 16(1):66. PubMed ID: 29669568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Health state utility values associated with advanced gastric, oesophageal, or gastro-oesophageal junction adenocarcinoma: a systematic review.
    Carter GC; King DT; Hess LM; Mitchell SA; Taipale KL; Kiiskinen U; Rajan N; Novick D; Liepa AM
    J Med Econ; 2015; 18(11):954-66. PubMed ID: 26212479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Health-related quality of life in patients with uveitis.
    Shamdas M; Bassilious K; Murray PI
    Br J Ophthalmol; 2019 Sep; 103(9):1284-1288. PubMed ID: 30361275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utility Measures in Pediatric Temporary Health States: Comparison of Prone Positioning Valuation Through 5 Assessment Tools.
    Shahjouei S; Vafaei Sadr A; Khorasani S; Nejat F; Habibi Z; Akbari Sari A
    Value Health Reg Issues; 2019 May; 18():97-105. PubMed ID: 30897544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estimation of Health State Utility Values in Fabry Disease Using Vignette Development and Valuation.
    Hughes D; Lenny A; Shah K; Longworth L; Devercelli G; Ayodele O
    J Health Econ Outcomes Res; 2023; 10(1):80-88. PubMed ID: 37064293
    [No Abstract]   [Full Text] [Related]  

  • 34. Measurement and comparison of health utility assessments in chronic rhinosinusitis.
    Ference EH; Stubbs V; Lidder AK; Chandra RK; Conley D; Avila PC; Hirsch AG; Min JY; Smith SS; Kern RC; Tan BK
    Int Forum Allergy Rhinol; 2015 Oct; 5(10):929-36. PubMed ID: 26077390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Population preference values for health states in relapsed or refractory B-precursor acute lymphoblastic leukemia in the United Kingdom.
    Aristides M; Barlev A; Barber B; Gijsen M; Quinn C
    Health Qual Life Outcomes; 2015 Nov; 13():181. PubMed ID: 26573610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quality-of-life valuations of advanced breast cancer by New Zealand women.
    Milne RJ; Heaton-Brown KH; Hansen P; Thomas D; Harvey V; Cubitt A
    Pharmacoeconomics; 2006; 24(3):281-92. PubMed ID: 16519549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reconsidering the use of rankings in the valuation of health states: a model for estimating cardinal values from ordinal data.
    Salomon JA
    Popul Health Metr; 2003 Dec; 1(1):12. PubMed ID: 14687419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preference-based quality of life of patients on renal replacement therapy: a systematic review and meta-analysis.
    Liem YS; Bosch JL; Hunink MG
    Value Health; 2008; 11(4):733-41. PubMed ID: 18194399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Eliciting health state utilities for Aromatic L-amino Acid Decarboxylase (AADC) deficiency: a UK vignette study.
    Smith AB; Hanbury A; Buesch K
    J Patient Rep Outcomes; 2021 Dec; 5(1):130. PubMed ID: 34897562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new explanation for the difference between time trade-off utilities and standard gamble utilities.
    Bleichrodt H
    Health Econ; 2002 Jul; 11(5):447-56. PubMed ID: 12112493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.